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Histone modifications play a major role in the
control of genes in their natural chromatin context.
A detailed, time-resolved analysis of histone modifi-
cations during gene activation has now revealed the
order of appearance of particular histone modifica-
tions on a promoter during regulatory processes.
The genetic information of each eukaryotic organism
is embedded in the context of chromatin, a complex
structure that not only serves to compact the genome
but plays a major role in the regulation of gene expres-
sion in vivo [1]. Chromatin is formed by the association
of a 147 base-pair stretch of DNA with a histone
octamer formed by two molecules of each of the four
core histones, H2A, H2B, H3 and H4 [2]. This nucleo-
somal structure is the basic building block of chro-
matin. Adjacent nucleosomes can fold into higher-
order structures, which can restrict the accessibility of
DNA to binding factors, such as basal and specific
transcription factors and RNA polymerases. The post-
translational modification of the histone amino-
terminal tails can increase or further decrease the
accessibility of DNA within chromatin; I will refer 
to these two states as ‘open’ or ‘closed’ chromatin
configurations, respectively. 
The many potential histone modifications, which in
principle can occur in a large number of combinations
(Figure 1), inspired a model in which a specific set of
modifications form a kind of ‘epigenetic code’. The
postulated code can have a very specific functional
output: for example, increased transcription or the for-
mation of particular chromatin structures such as the
centromere (reviewed in [3,4]). Several groups have
already shown that histone modifications, such as
acetylation or ubiquitination, can substantially influ-
ence the likelihood of further modifications, such as
phosphorylation or methylation [5–9]. But the exact
order of the histone modifications made during tran-
scriptional activation or repression has not been
addressed in detail.
In an elegant study published recently in Current
Biology, Daujat et al. [10] used the estrogen-responsive
promoter of the presenillin 2 gene (pS2) to study the
appearance of histone modifications during gene acti-
vation. The pS2 gene is well-known to be estrogen-
responsive, and the kinetics of its activation and of
estrogen receptor and transcriptional cofactor binding
to the promoter have been well characterised [11]. This
seems to be a particularly good system for such a
study, as it can easily be controlled experimentally by
addition of its natural ligand 17β estradiol. Upon ligand
binding, estrogen receptor molecules bind to estrogen-
response elements (EREs) within the promoters of
estrogen-responsive genes. The promoter-bound
receptor molecules recruit a variety of cofactors, which
in turn modify the chromatin structure at the promoter
and also attract the basal transcriptional machinery
(Figure 2).
These transcriptional coactivators fall into distinct
classes. One class consists of the nucleosome re-
modelling activities BRM/SNFα and BRG1/SNFβ, which
use the hydrolysis of ATP to reorganise chromatin
structure [12]. The second class consists of histone
acetyltransferases such as CBP, p300 and P/CAF,
which are thought either to directly change higher-order
chromatin folding or to act as ‘tagging’ factors which
mark a particular region of the genome [13]. Another
group of cofactors is the p160 family, which serve as
adaptor molecules to strengthen further the interaction
between the estrogen receptor and the transcriptional
coactivators mentioned above [14].
The idea that histone methylation contributes to the
full activation potential of nuclear hormone receptors
came from the finding of Chen et al. [15] that a protein,
which they termed coactivator associated arginine
methyltransferase 1 (CARM1), can interact specifically
with members of the p160 coactivator family (in a yeast
two-hybrid screen at least). CARM1, which shows sig-
nificant sequence similarity to known arginine methyl-
transferases, is able to methylate histone H3 at posi-
tions 17 and 26, and this methyltransferase activity is
essential for its ability to act as a coactivator [15].
Histone H3 methylated at arginine 17 is indeed found
to be enriched on hormone responsive promoters after
induction [16,17]. CARM1 acts synergistically with
other known coactivators, such as the acetyltrans-
ferases p300 and P/CAF [18], suggesting that histone
methylation and histone acetylation work together to
stimulate transcription to the full extent.
In the breast cancer cell line MCF7, induction of the
pS2 promoter by estrogen leads to an increased syn-
thesis of presenillin RNA, which is first detectable 15
minutes after hormone induction and continues to
increase for at least another 45 minutes. In their recent
work, Daujat et al. [10] analysed the change in histone
modifications during the first 60 minutes of transcrip-
tional activation, using antibodies directed against
specifically modified histones. Interestingly, they
found that, even in the absence of hormone, lysine 14
of histone H3 is already acetylated, and the levels of
lysine 14 acetylation do not change during the time
course of the experiment. 
The first detectable sign of coactivator function on
the presenillin promoter is acetylation of lysine 18 of
histone H3, which is found 15 minutes after hormone
induction. This acetylation in all likelihood results
from recruitment of the histone acetyltransferase CBP
by the estrogen receptor, as it can be mimicked by
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overexpression of CBP in the absence of ligand.
Methylation of arginine 17 of histone H3, shown pre-
viously to be associated with the transcriptionally
active presenillin promoter [16], is detected only 30
minutes after hormone induction, together with the
acetylation of lysine 23, which appears only tran-
siently at the promoter when it is fully active. 
These results indicate that histone modifications at
the induced pS2 promoter are highly interdependent
and formed in a stepwise manner. They also suggest
that the acetylation of lysine 18 is required for CARM1
mediated methylation. Indeed, in vitro methylation
experiments by Daujat et al. [10], using recombinant
CARM1, showed increased methylation of histones
that were pre-acetylated by p300, as well as of
chemically synthesised peptides carrying an acety-
lated lysine at position 18. This dependency might
reflect the increased substrate affinity of CARM1 for
the acetylated versus the unmodified peptide.
It is very tempting to speculate about the possible
benefits of this specific modification pattern at the
pS2 promoter. One could imagine that the methylation
of arginine 17 might serve as a mark that this pro-
moter has previously been activated. Alternatively,
methylation at lysine 17 might increase the efficiency
of nucleosome remodelling and transcriptional
reinitiation by generating a specific recognition site for
the corresponding factors (see Figure 2).
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Figure 1. A summary of reported histone
modifications.
Amino-terminal tails are depicted as solid
red lines; carboxy-terminal tails of H2A
and H2B, as well as the part of the H3 tail
located inside the DNA, are drawn as
dotted red lines.
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Figure 2. A model for estrogen-receptor-
mediated transcriptional activation.
(A) After hormone binding, estrogen
receptor is targeted to the pS2 promoter,
already preacetylated at lysine 14 of
histone H3 (green triangles). (B) The lig-
anded, DNA-bound estrogen receptor
recruits a transcriptional coactivator
complex consisting of CBP, p160 and
CARM1. The acetyltransferase CBP
acetylates lysine 18 of histone H3 (dark
blue triangles) within the first 15 minutes
after recruitment. This acetylation leads
presumably to a more open chromatin
structure and facilitates transcription initi-
ation by the RNA polymerase II. (C)
Histone H3 acetylated at lysines 18 and
23 serves as a high-affinity substrate for
CARM1, which then methylates arginine
17 on H3. This additional modification
leads to a further increase in transcription
by mechanisms which are still unclear.
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